MelamixTM
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
19.01.2021
Obituary: On the death of Professor Wolfram Sterry
Wolfram Sterry was born on March 5, 1949 in Marbach am Neckar. After graduating from high school in 1968, he did his military service in the German Armed Forces and […]
15.01.2019
The PicoStar Laser for Removal of Tattoos, Pigmented Lesions and Permanent Makeup
Tattoos have increased tremendously in popularity – a phenomenon that can be seen across the world. In France alone, the number of tattooists has increased ten-fold within a decade. Twenty […]